441 filings
6-K
CLLS
Cellectis
22 Apr 24
Cellectis Presents Novel TALENĀ® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
4:35pm
6-K
CLLS
Cellectis
10 Apr 24
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
4:35pm
6-K
CLLS
Cellectis
8 Apr 24
Current report (foreign)
4:35pm
SC 13G/A
CLLS
Cellectis
14 Feb 24
Cellectis / Long Focus Capital Management ownership change
5:07pm
SC 13G/A
PFE
Pfizer Inc.
14 Feb 24
Cellectis / PFIZER ownership change
2:24pm
6-K
CLLS
Cellectis
16 Jan 24
Current report (foreign)
4:45pm
6-K
CLLS
Cellectis
22 Dec 23
Current report (foreign)
4:35pm
6-K
CLLS
Cellectis
22 Dec 23
Current report (foreign)
4:01pm
6-K
CLLS
Cellectis
5 Dec 23
Current report (foreign)
4:01pm
SC 13G/A
Baillie Gifford & Co
5 Dec 23
Cellectis / BAILLIE GIFFORD & CO ownership change
7:18am
6-K
CLLS
Cellectis
17 Nov 23
Current report (foreign)
4:56pm
6-K
CLLS
Cellectis
17 Nov 23
Current report (foreign)
4:35pm
SC 13D/A
CLLS
Cellectis
16 Nov 23
Cellectis / ASTRAZENECA ownership change
11:16am
6-K
CLLS
Cellectis
15 Nov 23
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
7:48am
SC 13D/A
CLLS
Cellectis
13 Nov 23
Cellectis / Bpifrance Participations ownership change
3:04pm
SC 13D
CLLS
Cellectis
9 Nov 23
Cellectis / ASTRAZENECA ownership change
5:07pm
6-K
CLLS
Cellectis
9 Nov 23
Joint Researchand Collaboration Agreement
4:01pm
6-K
CLLS
Cellectis
6 Nov 23
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
4:35pm
6-K
CLLS
Cellectis
6 Nov 23
Current report (foreign)
4:30pm
6-K
CLLS
Cellectis
2 Nov 23
Current report (foreign)
4:35pm